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As part of the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South 
Africa (HAALSI), we investigated sleep habits and their interactions with HIV or non-communicable 
diseases (NCDs) in 5059 participants (median age: 61, interquartile range: 52—71, 54% females). Self-
reported sleep duration was 8.2 ± 1.6h, and bed and rise times were 20:48 ± 1:15 and 05:31 ± 1:05 
respectively. Ratings of insufficient sleep were associated with older age, lack of formal education, 
unemployment, and obesity (p < 0.05). Ratings of restless sleep were associated with being older, 
female, having more education, being unemployed, and single. Hypertension was associated with 
shorter self-reported sleep duration, poor sleep quality, restless sleep, and periods of stopping 
breathing during the night (p < 0.05). HIV positive individuals not on antiretroviral treatment (ART) 
reported more nocturnal awakenings than those on ART (p = 0.029) and HIV negative individuals 
(p = 0.024), suggesting a negative net effect of untreated infection, but not of ART, on sleep quality. In 
this cohort, shorter, poor-quality sleep was associated with hypertension, but average self-reported 
sleep duration was longer than reported in other regions globally. It remains to be determined whether 
this is particular to this cohort, South Africa in general, or low- to middle-income countries undergoing 
transition.
While the global prevalence of non-communicable diseases (NCDs) continues to increase, the burden of NCDs is 
growing at a faster rate in developing countries. Those in earlier stages of epidemiological transition or where the 
speed of transition is most rapid are thought to be most vulnerable. South Africa is considered to be a developing 
upper-middle income country, experiencing a demographic and epidemiologic transition, and currently facing a 
quadruple burden of disease — the simultaneous occurrence of infectious disease epidemics, high prevalence of 
NCDs, perinatal and maternal health challenges, and high levels of injury and violence-related deaths.
Historically, infectious diseases have represented the primary burden in South Africa, culminating in the HIV 
epidemic. The total population prevalence of HIV infection is estimated to be 12.2%, higher in females (14.4%) 
than in males (9.9%)1. The prevalence of NCDs, however, is increasing rapidly. In 2015, national data indicated 
that NCDs such as heart disease, cancer, diabetes and stroke were responsible for 56% of all deaths occurring that 
year. In fact, type 2 diabetes mellitus (T2DM) is now the second most common cause of death in South Africa 
(5.4%), after tuberculosis (7.2%)2. Because a major risk factor for cardiovascular diseases (CVD) and T2DM is 
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obesity, it is concerning that one third of South African males and two thirds of South African females are over-
weight or obese1.
Although sleep is affected by and affects both infectious diseases and NCDs, it is a frequently neglected aspect 
of health and well-being. Sleep has been reported to be affected by HIV infection and some of the anti-retroviral 
treatments (ART) prescribed to treat it3–7. For example, there have been reports of sleep disturbances associated 
with one of the common ARTs for HIV, efavirenz5,6. Although some high-income countries have moved away 
from it as first-line therapy, efavirenz remains one of the drugs included in the first line treatment for HIV in 
South Africa8.
Insufficient and/or mistimed sleep is also a major risk factor for obesity and NCDs such as CVD and T2DM9. 
Several prospective cohort studies indicate that both short and long sleep are associated with higher mortality 
rates and increased risk for CVD10–13. US National Health Interview Survey data indicate that relative to sleeping 
7–8 h per night, self-reported short (≤6 h) and long sleep (>9 h) duration are independently associated with 
increased obesity, T2DM, hypertension, and CVD14. An added complication is the association between obesity 
and obstructive sleep apnoea (OSA), a known cardiovascular risk factor that is additive to the effects of obesity 
alone15.
Few studies have investigated the sleep habits of South Africans and other Africans, let alone the interac-
tions between sleep and the increasingly common chronic conditions associated with HIV and NCDs. The 
assumption that changes in sleep patterns coincided with the other lifestyle changes underlying epidemiologic 
transitions is one reason why sleep in communities that are at different stages of the urbanisation process is 
of considerable interest. A study in hunter-gatherer communities (two in Africa and one in South America) 
found actigraphy-derived time-in-bed ranging between 6.9 and 8.5 h and total sleep times between 5.7 and 7.1 h16. 
However, the generalisability of these observations has been questioned, on the basis of the marginal living condi-
tions of these communities17. A recent study in a transitioning African society showed that objectively measured 
total sleep time was not affected by having access to electricity, but rather, the timing of sleep was affected18.
Collectively, the sleep data available to date on South Africans are variable, which is unsurprising given the 
diversity of cultures, socio-economic status, living conditions, education attained and employment rates. A recent 
report19 described self-reported sleep habits of urban South Africans living in Soweto. Long self-reported sleep 
times (8.75 ± 1.72 h) were documented, and 29% of the participants routinely napped during the day. Females 
reported longer sleep times than males, and self-reported sleep duration was negatively associated with body 
mass index (BMI) in females older than 40 years of age, and positively associated with blood pressure, regardless 
of age. While 6.4% of this urban population were confirmed to be HIV positive, the study did not examine any 
associations between HIV status, ART, and sleep19. More recently, a study in a nationally representative sample 
of older South Africans (>50 y) in the Global Study on Ageing (SAGE) observed ethnic group differences in 
self-reported sleep duration20. This study reported that short sleep was more prevalent in white Africans than 
non-white Africans even after accounting for covariates such as age, gender, education, wealth status, residence 
and chronic disease. The study did not investigate any associations between self-reported sleep duration and HIV 
or NCDs.
The Agincourt Health and Demographic Surveillance System site was established in 1992 in Agincourt 
sub-district, one of the most deprived rural areas of South Africa, to better understand the demographic and 
epidemiologic transitions of this rural population21. Older individuals (>50 y, n = 4044) were asked two questions 
to establish the severity of any nocturnal sleep problems and the extent to which the quality and/or quantity of 
their sleep affected their daytime function. A third of the population (30.2%) reported having severe/extreme 
nocturnal sleep problems, and 17.9% indicated that their daytime function was severely/extremely affected by 
their nocturnal sleep problems. Males who reported feeling unrested or unrefreshed during the day had a 2-fold 
increased mortality risk22.
The Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa 
(HAALSI) study investigates NCDs in a similar ageing segment of the Agincourt cohort23. Responses to a mod-
ified version of the Pittsburgh Sleep Quality Index (PSQI) questionnaire24 were captured during this study. The 
responses to these questions are presented here, and have allowed us to derive information about sleep quality 
and duration, and relate these to NCDs, as well as HIV status and medication use. Therefore, the aims of this study 
were to (i) describe aspects of self-reported sleep duration and quality within this cohort of older, rural, black 
South Africans, and (ii) explore relationships between self-reported sleep duration, timing and quality and HIV 
status, ART, and NCDs.
Results
Characteristics of the study cohort. Descriptive data for the 5059 rural participants included in this 
study are presented in Table 1. Males had on average received more years of education than females (p < 0.001), 
and more male participants were currently married (p < 0.001), lived in smaller households (p = 0.004) and were 
employed (p < 0.001). One third of this cohort was classified as obese, 58% hypertensive, 11% diabetic, 23% HIV 
positive, and almost 15% were taking ART. Females had higher BMIs (p < 0.001) and were more likely to be 
obese (p < 0.001), hypertensive (p < 0.001) and anaemic (p < 0.001) than the males. Although 94% of this cohort 
reported having good sleep quality, 32% took longer than 30 minutes to fall asleep at night, 36% felt that their 
self-reported sleep duration was insufficient, 33% experienced restless sleep, 40% were aware of nocturnal awak-
enings, 20% reported snoring, 12% reported gasping, and 7% reported that they stop breathing for brief periods 
in the night. Sleep habits also differed between sexes. Females reported shorter sleep durations (p < 0.001), going 
to bed earlier (p = 0.023), and waking earlier (p < 0.001) compared to males. Fewer females reported getting suf-
ficient sleep each night (p = 0.005), more females experienced restless sleep (p < 0.001) and nocturnal awakenings 
(p = 0.008) than males, and more males reported snoring than females (p = 0.008). Figure 1 shows the sex-strati-
fied distributions of bedtime, wake-up time, sleep and total sleep time for all participants.
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Sleep parameter associations. Table 2 displays associations between demographic and sleep parame-
ters. Self-reported sleep duration was associated with age, sex, employment, marital status, and wealth quin-
tile. Participants aged 50–59 y (p = 0.030) and 60–69 y (p < 0.001) had shorter self-reported sleep durations than 
40–49-year-olds; females reported shorter sleep durations than males (p < 0.001); employed individuals and 
homemakers reported shorter sleep durations than those not working (p < 0.001); married individuals reported 
shorter sleep durations than those divorced (p = 0.037) or widowed (p = 0.003), and middle, upper-middle 
and upper income individuals reported shorter sleep durations than individuals in the lowest wealth quintile 
(p = 0.024, p = 0.001, and p = 0.005, respectively).
All (n = 5059)
Females 
(n = 2714) Males (n = 2345) p-value
Age (y) 61 (52–71) 60 (51–71) 61 (52–71) 0.594
Years of education 4 (1–9) 3 (1–9) 5 (1–9) <0.001
Married/cohabiting 2575 (50.9%) 973 (35.9%) 1602 (68.3%) <0.001
Number of people in household 5.3 ± 3.3 5.5 ± 3.3 5.2 ± 3.4 0.004
Employed 805 (16.0%) 362 (13.4%) 443 (19.0%) <0.001
Household wealth quintile
   1 (poorest) 1046 (20.7%) 544 (20.0%) 502 (21.4%) 0.614
   2 1001 (19.8%) 546 (20.1%) 455 (19.4%)
   3 991 (19.6%) 541 (19.9%) 450 (19.2%)
   4 1007 (19.9%) 550 (20.3%) 457 (19.5%)
   5 (wealthiest) 1014 (20.0%) 533 (19.6%) 481 (20.5%)
BMI (kg·m−2) 27.2 ± 6.9 29.3 ± 7.4 24.9 ± 5.4 <0.001
Obese 1384 (29.5%) 1043 (41.2%) 341 (15.8%) <0.001
Hypertension 2884 (58.4%) 1645 (61.8%) 1239 (54.5%) <0.001
Dyslipidemia 1861 (43.8%) 1000 (42.9%) 861 (44.9%) 0.203
Diabetes 495 (10.7%) 288 (11.5%) 207 (9.7%) 0.050
Anemia 779 (17.3%) 544 (22.5%) 235 (11.4%) <0.001
HIV positive 1048 (23.0%) 565 (22.9%) 483 (23.0%) 0.944
HIV+ and on ART 663 (64.0%) 346 (61.8%) 317 (66.6%) 0.108
Sleep duration* (h) 8.23 ± 1.6 8.15 ± 1.6 8.33 ± 1.7 <0.001
Bedtime (h:min) 20:48 ± 1:15 20:46 ± 1:13 20:51 ± 1:18 0.023
Wake time (h:min) 05:31 ± 1:05 05:22 ± 1:00 05:41 ± 1:10 <0.001
Good sleep qualitya 4724 (93.5%) 2527 (93.2%) 2197 (93.8%) 0.458
Latency > 30 minb 1603 (31.8%) 861 (31.9%) 742 (31.8%) 0.952
Sufficient sleepc 3241 (64.2%) 1691 (62.4%) 1550 (66.2%) 0.005
Restless sleep 1626 (32.9%) 964 (36.3%) 662 (28.9%) <0.001
Nocturnal awakeningsc 2036 (40.3%) 1139 (42.0%) 897 (38.3%) 0.008
Snoringd 979 (19.5%) 488 (18.1%) 491 (21.1%) 0.008
Gaspingd 624 (12.4%) 313 (11.6%) 311 (13.4%) 0.065
Breathing stopsd 352 (7.0%) 177 (6.6%) 175 (7.5%) 0.203
Table 1. Descriptive, demographic, health and sleep characteristics of the cohort. Data are presented 
as mean ± standard deviation, median (interquartile range) or count (%). BMI: body mass index; ART: 
antiretroviral therapy. *Self-reported sleep duration. a“Very good” or “Fairly good”; bOnce a week or more; 
c“Often” or “Very often”; d“Yes”. The p-values represent differences between the two gender groups analyzed 
using an independent t-test, a Mann-Whitney U test or a Fisher’s Exact test.
Figure 1. Histograms of self-reported bedtime (a), wake time (b) and sleep duration (c), stratified by sex.
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Self-reported bedtime was associated with age, BMI, education level, marital status and wealth quintile. 
Individuals aged 70–79 y (p = 0.058) and ≥80 y (p < 0.001) had earlier bedtimes than those aged 40–49 y; under-
weight participants had earlier bedtimes than normal weight participants (p = 0.006); individuals with 1–7 y 
(p = 0.005) or >12 y (p = 0.002) of education had later bedtimes than those with no formal education; widowed 
individuals had earlier bedtimes than married individuals (p = 0.001); middle, upper-middle and upper income 
individuals had later bedtimes than those in the lowest wealth quintile (p = 0.002, p < 0.001 and p < 0.001 respec-
tively). Waking time was associated with age, sex, employment status and marital status. Participants aged 50–69 y 
woke earlier than 40–49-year-olds (p < 0.001 females woke earlier than males (p < 0.001), employed individuals 
woke earlier than others (p < 0.001), and currently married individuals woke earlier than those not married 
(p < 0.001), separated/divorced (p < 0.001), or widowed (p = 0.009).
Ratings of insufficient sleep were associated with age, BMI, level of education, and employment sta-
tus. Participants older ≥80 y were more likely to rate their sleep duration as being insufficient compared to 
40–49-year-olds (p = 0.025); obese individuals were more likely to rate their sleep as being insufficient compared 
to normal weight individuals (p = 0.001); those with 8 to 11 years of education (p = 0.001) and those with 12 
+years of education (p = 0.017) were less likely to rate their sleep as being insufficient compared to those with no 
formal education; and homemakers were less likely to rate their sleep as being insufficient compared to those not 
working (p < 0.001).
Ratings of restless sleep were associated with age, sex, education level, employment and marital status. 
Individuals ≥50 y were more likely to report restless sleep compared to those aged 40–49 y (p < 0.001); females 
were more likely to report restless sleep than males (p = 0.001); those with ≥ 12 years of education were less likely 
to report restless sleep compared to those with no formal education (p < 0.001); employed individuals were less 
likely to report restless sleep compared to those not working (p = 0.011); and separated/divorced (p = 0.002) and 
widowed (p < 0.001) participants were more likely to report restless sleep compared to married participants.
Self-reported snoring was associated with age, sex, BMI, education level and marital status. Participants ≥ 50 y 
were more likely to report snoring than 40–49-year-olds (p = 0.044 for 50–59 y, p < 0.001 for 60–69 y, p = 0.004 
for 70–79 y, p < 0.001 for ≥ 80 y); overweight (p = 0.009) and obese (p < 0.001) individuals were more likely to 
report snoring compared to normal weight individuals; males were more likely to report snoring than females 
(p < 0.001); those with 1–7 y of education were more likely to report snoring compared to those with no formal 
education (p = 0.005); and separated/divorced (p = 0.031) and widowed (p < 0.001) participants were less likely 
to report snoring compared to those currently married.
Self-reported 
sleep duration Bedtime Wake time Insufficient sleep Restless sleep Snoring
Quartile 1 - 
Quartile 4
Quartile 1 - 
Quartile 4
Quartile 1 - 
Quartile 4
Sometimes/Rarely/
Never sufficient vs. 
Often/Very often 
sufficient Yes vs. No Yes vs. No
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age group (y)
50–59 vs 40–49 0.83 (0.70, 0.98) 1.00 (0.85, 1.17) 0.76 (0.64, 0.89) 1.13 (0.93, 1.37) 1.39 (1.12, 1.72) 1.28 (1.00, 1.63)
60–69 vs 40–49 0.78 (0.65, 0.94) 0.99 (0.83, 1.19) 0.61 (0.51, 0.73) 1.04 (0.84, 1.29) 1.79 (1.42, 2.25) 1.64 (1.26, 2.13)
70–79 vs 40–49 0.93 (0.76, 1.15) 0.75 (0.61, 0.92) 0.85 (0.69, 1.04) 1.15 (0.91, 1.47) 1.97 (1.53, 2.54) 1.54 (1.14, 2.07)
80+ vs 40–49 1.24 (0.97, 1.59) 0.53 (0.41, 0.67) 1.18 (0.93, 1.51) 1.37 (1.04, 1.81) 2.46 (1.84, 3.29) 1.80 (1.27, 2.55)
Sex Female vs Male 0.73 (0.64, 0.83) 0.93 (0.82, 1.05) 0.50 (0.44, 0.57) 1.05 (0.91, 1.21) 1.28 (1.10, 1.49) 0.74 (0.62, 0.88)
BMI
Underweight vs normal 1.01 (0.79, 1.30) 0.71 (0.55, 0.90) 1.06 (0.83, 1.35) 1.09 (0.82, 1.44) 1.27 (0.95, 1.69) 1.34 (0.94, 1.89)
Overweight vs normal 1.03 (0.90, 1.19) 0.97 (0.84, 1.11) 0.91 (0.79, 1.04) 1.14 (0.97, 1.33) 1.14 (0.97, 1.34) 1.30 (1.07, 1.60)
Obese vs normal 1.08 (0.93, 1.24) 1.06 (0.92, 1.22) 1.10 (0.95, 1.26) 1.30 (1.11, 1.53) 1.02 (0.86, 1.20) 2.50 (2.05, 3.05)
Education
1–7 years vs No formal education 0.89 (0.78, 1.02) 1.19 (1.05, 1.35) 1.02 (0.9, 1.16) 0.93 (0.81, 1.08) 0.94 (0.81, 1.09) 1.29 (1.08, 1.53)
8–11 years vs No formal education 0.96 (0.79, 1.16) 1.18 (0.97, 1.43) 1.17 (0.97, 1.42) 0.67 (0.53, 0.85) 0.82 (0.64, 1.04) 1.09 (0.83, 1.44)
12+ years vs No formal education 0.82 (0.64, 1.03) 1.45 (1.15, 1.83) 0.81 (0.64, 1.02) 0.71 (0.54, 0.94) 0.50 (0.36, 0.70) 1.23 (0.89, 1.70)
Employment
Employed vs Not working 0.57 (0.48, 0.67) 1.00 (0.86, 1.18) 0.43 (0.36, 0.50) 0.94 (0.78, 1.13) 0.76 (0.62, 0.94) 0.99 (0.79, 1.24)
Homemaker vs Not working 0.45 (0.37, 0.54) 0.88 (0.74, 1.05) 0.96 (0.80, 1.14) 0.34 (0.27, 0.43) 0.86 (0.70, 1.06) 1.20 (0.95, 1.52)
Marital status
Never married vs Currently 
married 1.18 (0.92, 1.51) 0.95 (0.75, 1.20) 1.57 (1.24, 1.99) 1.10 (0.84, 1.46) 1.14 (0.83, 1.56) 0.82 (0.57, 1.17)
Separated/divorced vs Currently 
married 1.20 (1.01, 1.43) 0.85 (0.71, 1.00) 1.35 (1.13, 1.59) 1.15 (0.94, 1.40) 1.38 (1.12, 1.69) 0.76 (0.59, 0.97)
Widowed vs Currently married 1.23 (1.07, 1.42) 0.79 (0.69, 0.91) 1.20 (1.04, 1.38) 1.13 (0.96, 1.33) 1.33 (1.13, 1.57) 0.66 (0.54, 0.81)
Wealth quintile
2 vs 1 (lowest) 0.94 (0.79, 1.11) 1.21 (1.03, 1.44) 0.92 (0.77, 1.08) 1.11 (0.92, 1.35) 0.91 (0.75, 1.11) 0.86 (0.68, 1.10)
3 vs 1 0.81 (0.68, 0.97) 1.31 (1.11, 1.56) 0.90 (0.76, 1.07) 0.93 (0.76, 1.14) 1.09 (0.89, 1.33) 0.93 (0.73, 1.18)
4 vs 1 0.73 (0.61, 0.87) 1.66 (1.40, 1.97) 0.99 (0.83, 1.18) 1.03 (0.84, 1.26) 1.05 (0.85, 1.29) 0.92 (0.72, 1.18)
5 vs 1 0.76 (0.63, 0.92) 1.83 (1.52, 2.19) 0.99 (0.83, 1.19) 1.05 (0.85, 1.30) 0.89 (0.72, 1.11) 0.88 (0.68, 1.14)
Table 2. Logistic regression models for associations between demographic and sleep variables. Each of the 
six sleep parameters (dependent variables) was evaluated in a separate model with the demographic variables 
serving as independent variables. OR: odds ratio, CI: confidence interval, BMI: body mass index.
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Sleep and health outcomes. Associations between self-reported sleep parameters and health outcomes 
are presented in Table 3. Obesity was associated with self-reported bedtime, wake time, insufficient sleep, snor-
ing, gasping and periods of stopping breathing during sleep. Those reporting bedtimes between 21:00–21:30 
(p = 0.012) and wake times from 05:00–06:00 (p = 0.019) were more likely to be obese than those going to bed 
before 21:00 and waking up before 05:00 respectively. In addition, those reporting not getting enough sleep 
(p = 0.008), snoring (p < 0.001), gasping (p < 0.001) and have breathing pauses (p < 0.001) during the night were 
also more likely to be obese. Hypertension was associated with self-reported sleep duration, bedtime, wake time, 
sleep quality, restless sleep, and periods of stopping breathing during the night. In this cohort, those with earlier 
bedtimes (<21:00, p = 0.028), early waking times (<05:00, p = 0.030), better sleep quality (p = 0.010), less rest-
less sleep (p = 0.011) and those not reporting periods of stopping breathing (p = 0.009) were less likely to have 
hypertension.
Diabetes was associated with bedtime, restless sleep, and snoring. Participants reporting the latest bedtimes 
(>21:30) were less likely to have diabetes compared to those with the earliest bedtimes (<20:00, p = 0.047); those 
reporting restless sleep were more likely to have diabetes than those not reporting restless sleep (p = 0.015); and 
those reporting snoring were more likely to have diabetes compared to those not reporting snoring (p = 0.003). 
Dyslipidaemia was only associated with sleep sufficiency such that those reporting insufficient sleep were more 
likely to have dyslipidemia compared to those who felt they were obtaining sufficient sleep (p = 0.032). Anaemia 
was associated with self-reported sleep duration such that individuals in the shortest (4–7 h, p = 0.041) and long-
est (>= 10 h, p = 0.007) sleep quartiles were more likely to have anaemia compared to those in the second sleep 
quartile (8 h). HIV infection was associated with bedtime only: participants with moderately early bedtimes 
(20:00 to <21:00) were more likely to be HIV positive compared to those with the earliest bedtimes (<20:00, 
p = 0.025).
ART and viral load associations with sleep parameters. While HIV positive individuals not on 
ART reported more awakenings during the night compared to those on ART (p = 0.024; Table 4), viral load 
amongst the HIV positive participants was not associated with any of the self-reported sleep parameters meas-
ured (Supplementary Table 1).
Discussion
This cohort of older, rural, black South African adults reported a longer sleep duration (8.2 ± 1.6 h per night) 
than observed in other populations globally, despite the fact that one third described their sleep duration as being 
insufficient. A study of self-reported sleep duration and sleep problems in older adults found that participants 
from South Africa reported sleep durations of 8.6 h (SD ± 2.1), and a greater proportion of rural dwelling partic-
ipants than urban dwellers reported sleep durations >10 h25. A review of data from 168 studies around the world 
(n = 6052) between 2010 and 2015 found total sleep time (actigraphy- or PSG-derived) to range between 5.8 and 
7.8 h per night26. Other large-scale epidemiological studies have observed self-reported median sleep durations 
of 7–8 h27–30. Although self-reported sleep duration is typically longer than objectively measured total sleep time, 
possible explanations for the longer self-reported sleep duration observed in this study may relate to differences 
in ethnicity (or tribal origin), geographical region, culture, proportion of females, age, employment status, level 
of education, or a rural living environment.
There may be a strong argument relating to ethnicity, or culture, since three other South African cohorts 
have also found longer self-reported sleep durations (8.5–10.5 h per night) in black South African adults19,20,31. 
Since a previous study20 reported longer sleep durations in black Africans than in the other ethnic groups living 
in South Africa, it is tempting to surmise that a longer self-reported sleep duration is particular to ethnicity or 
culture in this setting. Interestingly, data from the 2005–2012 National Health and Nutrition Examination Survey 
(NHANES) in the USA indicated that non-Hispanic black Americans reported shorter sleep durations than other 
ethnic groups32. Furthermore, a meta-analysis comparing the sleep of African-Americans to European-Americans 
using polysomnography, actigraphy, diaries and questionnaires found that African-Americans had shorter total 
sleep time (objectively and subjectively measured) and poorer quality sleep, as measured by worse sleep efficiency, 
longer sleep onset latency and less slow wave sleep33. Therefore, it is important to try to disentangle the factors 
underlying these variations between ethnic groups in different countries with disparate socio-economic histories 
which appear to reoccur in spite of variability in general lifestyle and culture.
Longer self-reported sleep duration has been shown to be more prevalent in adults younger than 25 years 
or older than 60 years in the United States34. The longer self-reported sleep duration observed in the present 
study may be, at least in part, due to the older age of the cohort. Counter to this argument, however, is that those 
between 50 and 70 years old in this study reported shorter sleep durations than the 40-year-olds, and the sleep 
durations reported in previous South African studies, 8.75 h19 and 10.35 h31, were both longer than this study, 
despite the younger ages of their participants (39.9 years and 33.4 years respectively). There is evidence to suggest 
that males typically have longer, better quality sleep than females (reviewed in35). Since our sample was mildly 
biased towards females (54%), whose average sleep duration was 8.15 h, sex seems unlikely to explain the longer 
self-reported sleep duration observed in this cohort.
Another point to consider relates to employment. A study of adults in the USA found that being employed 
had a strong effect on reducing self-reported sleep duration34. Since only 16% of the individuals in the present 
study were employed, the longer sleep durations are not unexpected, and indeed employed individuals from this 
cohort did report shorter sleep durations. At odds with our observation is that the Soweto cohort, in whom the 
employment rate was nearly double (30%), reported longer sleep durations19. Of interest, too, is that despite the 
lower proportion of females in paid employment in this study, they reported earlier rise times and shorter sleep 
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durations than the males. This is the opposite of what was observed in Soweto, Finland, Norway, the UK and 
Canada19,27,36,37.
One might also argue that the longer sleep durations reported in this study relate to a rural living environment. 
Norwegian36 and South African studies25 have observed that individuals living in rural areas reported longer sleep 
durations than those in urban areas. However, the fact that an urban, albeit younger, population in Soweto, South 
Africa reported a longer sleep duration (8.8 ± 1.7 h)19, counters this argument. Generally, self-reported sleep 
durations from native Africans living in South Africa — those reported in the Soweto cohort19, the black African 
participants from the SAGE cohort25 and the black South Africans from the Modelling the Epidemiological 
Transition Study (METS) cohort31 — are all similar to those reported in the present study. We note that the sleep 
durations reported in this study are also similar to the objectively measured sleep periods (i.e. time-in-bed) in 
rural (9.23 ± 0.13 h) and semi-rural (8.78 ± 0.18 h) African communities in Mozambique18 but longer than those 
measured in southern African hunter-gathers (6.9–8.5 h) (Yetish, 2015, #3241}. We interpret these comparisons, 
with caution, however, owing to the different data collection methods used.
Thus, these findings raise interesting questions. Do South Africans, and in particular those of black African 
ancestry, have different sleep habits or even different sleep needs compared to other populations? Are these 
self-reported findings truly indicative of longer sleep, or could self-reported sleep in this cohort be subject to 
interpretation bias? Could this longer sleep period indicate sleep quality issues? What does the sleep period and 
NCD risk profile association look like in this group? To truly address these questions, future studies making use of 
objective sleep measures are required. The regression analyses from the present study do, however, provide some 
insight to the latter questions.
Data from the WHO indicate that the two strongest contributing risk factors to NCD-related deaths in South 
Africa are elevated blood pressure (33.7%) and obesity (31.3%)38. This sample of rural, older, longer sleeping 
adults was on average overweight, and had a high prevalence of obesity (30%) and hypertension (58%). Similar 
to the SA-NHANES report1, the incidence of obesity and hypertension was higher in the females in this study 
than in the males. The females also had higher incidences of depression and anaemia than the males. This higher 
burden of disease in the females was coincident with less formal education, larger households and lower employ-
ment. Since they also spent fewer hours in bed, had earlier wake times and reported more restless sleep and 
nocturnal awakenings than the males, one might speculate that their shorter, poorer quality sleep places them at 
higher risk for cardiometabolic diseases.
Prospective cohort studies indicate that both long- and short-total sleep times are associated with higher 
mortality rates and risk for cardiometabolic diseases10–13,39. In a recent large-scale study in the USA, 7 h of sleep 
was associated with the lowest risk for cardiometabolic disease in all ethnic groups except non-Hispanic blacks, 
in whom 8 h of sleep was associated with the lowest risk score for cardiometabolic disease32. As in previous 
studies40,41, the long sleepers (>10 h) in the present study had a lower incidence of hypertension than the shorter 
sleepers (<7 h). Sleep timing and ratings of sufficiency also appear to be important contributors to obesity in 
this cohort, since we observed an association between later bedtimes, ratings of insufficient sleep and obesity. A 
Obesity Hypertension Dyslipidemia Diabetes Anemia HIV
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
(1) Self-reported 
sleep duration
Quartile 1 (4–7 h) vs 2 (8 h) 0.97 (0.82, 1.17) 1.18 (1.00, 1.39) 0.94 (0.79, 1.12) 1.12 (0.86, 1.47) 1.26 (1.01, 1.58) 1.05 (0.86, 1.29)
Quartile 3 (9 h) vs 2 (8 h) 1.06 (0.87, 1.30) 1.12 (0.93, 1.35) 0.99 (0.82, 1.20) 1.02 (0.75, 1.38) 1.19 (0.92, 1.52) 1.19 (0.95, 1.49)
Quartile 4 (10–14 h) vs 2 (8 h) 1.07 (0.86, 1.33) 0.84 (0.69, 1.03) 0.88 (0.72, 1.09) 1.31 (0.96, 1.79) 1.43 (1.10, 1.86) 1.08 (0.84, 1.38)
(2) Bedtime
Quartile 2 (8- <9 pm) vs 1 (<8 pm) 1.22 (0.96, 1.55) 1.15 (0.94, 1.42) 0.94 (0.75, 1.17) 1.01 (0.72, 1.40) 0.96 (0.73, 1.26) 1.35 (1.03, 1.76)
Quartile 3 (9–9:30 pm) vs 1 (<8 pm) 1.36 (1.07, 1.73) 1.26 (1.02, 1.56) 1.10 (0.88, 1.37) 0.80 (0.57, 1.12) 0.99 (0.75, 1.30) 1.21 (0.93, 1.58)
Quartile 4 (>9:30 pm) vs 1 (<8 pm) 1.24 (0.96, 1.60) 1.11 (0.89, 1.39) 0.96 (0.76, 1.22) 0.68 (0.47, 0.99) 0.96 (0.71, 1.28) 1.14 (0.86, 1.52)
(3) Wake time
Quartile 2 (5 am) vs 1 ( < 5 am) 1.15 (0.95, 1.40) 0.81 (0.68, 0.98) 1.01 (0.83, 1.22) 1.22 (0.91, 1.64) 0.95 (0.75, 1.21) 0.92 (0.74, 1.15)
Quartile 3 (>5–6 am) vs 1 (<5 am) 1.27 (1.04, 1.55) 0.98 (0.81, 1.18) 1.07 (0.88, 1.30) 1.05 (0.77, 1.43) 1.00 (0.79, 1.28) 1.14 (0.91, 1.42)
Quartile 4 (>6 am) vs 1 (<5 am) 1.23 (0.97, 1.57) 0.96 (0.77, 1.19) 1.02 (0.81, 1.27) 1.36 (0.96, 1.93) 1.14 (0.85, 1.51) 0.99 (0.75, 1.29)
(4) Sleep quality Bad vs good 0.82 (0.61, 1.11) 1.43 (1.08, 1.90) 1.28 (0.98, 1.68) 1.08 (0.72, 1.64) 1.33 (0.96, 1.84) 0.76 (0.53, 1.09)
(5) Latency > 30 min At least once/week vs. <once/week 0.97 (0.84, 1.12) 1.08 (0.94, 1.23) 1.01 (0.88, 1.16) 1.10 (0.89, 1.36) 1.09 (0.91, 1.30) 0.93 (0.78, 1.09)
(6) Insufficient sleep Sometimes/rarely/never sufficient vs often/very often sufficient 1.21 (1.05, 1.40) 1.10 (0.96, 1.26) 1.16 (1.01, 1.33) 0.89 (0.72, 1.10) 1.05 (0.88, 1.25) 0.93 (0.79, 1.09)
(7) Restless sleep Yes vs no 0.95 (0.82, 1.10) 1.19 (1.04, 1.37) 1.06 (0.92, 1.22) 1.29 (1.05, 1.60) 1.04 (0.87, 1.25) 0.86 (0.72, 1.02)
(8) Nocturnal 
awakenings At least once/week vs < once/week 0.96 (0.84, 1.10) 1.12 (0.98, 1.27) 0.97 (0.85, 1.10) 1.02 (0.83, 1.25) 0.99 (0.84, 1.18) 1.09 (0.93, 1.27)
(9) Snoring Yes vs no 2.18 (1.85, 2.57) 1.15 (0.98, 1.35) 0.97 (0.82, 1.14) 1.41 (1.12, 1.78) 0.82 (0.65, 1.02) 0.89 (0.72, 1.09)
(10) Gasping Yes vs no 2.13 (1.75, 2.59) 1.07 (0.88, 1.30) 0.93 (0.76, 1.13) 1.27 (0.97, 1.67) 0.90 (0.69, 1.18) 1.05 (0.82, 1.34)
(11) Breathing stops Yes vs no 1.77 (1.37, 2.30) 1.42 (1.09, 1.85) 0.94 (0.72, 1.21) 1.29 (0.91, 1.83) 1.10 (0.79, 1.53) 0.85 (0.60, 1.20)
Table 3. Logistic regression models for associations between sleep parameters and health conditions. Each 
of the six health conditions (dependent variables) was evaluated in a separate model for each off the 11 sleep 
variables (independent variables), adjusted for BMI category and demographic characteristics (age group, 
sex, education group, employment status, marital status, wealth index quintile). The obesity outcome was not 
adjusted for BMI. OR: odds ratio, CI: confidence interval, BMI: body mass index.
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previous study in a cohort of black South Africans living in Soweto reported that a longer total sleep time and 
naps appeared to be protective against a high BMI in older females and high blood pressure, BMI and abdomi-
nal obesity in males19. Collectively, these data suggest that optimal sleep need may well differ by ethnicity in the 
context of minimising risk for NCDs. It is also worth noting that although we did not assess sleep apnoea, there 
are indications that this cohort may suffer from the condition, which may be contributing to poorer health since 
those reporting snoring, gasping or having breathing pauses during the night were more likely to be obese.
The relationship between HIV infection, and its treatment, is complex. Sleep disturbances are a known effect 
of HIV infection3. This occurs already at an early stage of the infection, and has been suggested to be associated 
with chronic activation of the immune system4,42. HIV infection in itself has neurotoxic effects, quite apart from 
the effects of any opportunistic pathogens (reviewed in43). It is also well known that patients taking efavirenz, 
one of the common ART for HIV, experience insomnia and other sleep disturbances such as longer sleep onset 
latency and shorter sleep duration, in particular in the earlier stages of treatment5,6. Electroencephalogram moni-
toring has shown longer sleep latency and shorter duration of deep sleep in patients taking efavirenz5, with higher 
plasma concentrations of efavirenz associated with insomnia5,7. Although it has been reported that some patients 
stop taking efavirenz as they find the sleep disturbances too debilitating7,44, long-term studies find that for most 
patients these and other neurological and psychiatric side-effects are transient and do not last beyond the first 
four weeks of treatment45,46. Further, the immunoprotective effects of ART have a paradoxical effect when suc-
cessful treatment commences at an advanced stage of the infection. It has been shown that a high increase in CD4 
counts, although a sign of restored immune function, also associates with lower sleep quality (as well as higher 
incidence of pain and depression)42. Our finding that participants with untreated HIV infection and a high viral 
load reported more nocturnal awakenings than HIV negative participants (p = 0.024) is consistent with previous 
reports of an effect of the infection on sleep quality. Our finding of less self-reported sleep disturbance in treated 
than in untreated HIV positive participants are not suggestive of a negative net effect on sleep of ART treatment, 
either via the effects of the ART drugs or via an asssociated CD4 rebound, in this older population. Although 
based on self-reported data on sleep quality and quantity, these data do not support any suggestion of replacing 
efavirenz as first-line treatment specifically because of its effects on sleep, at least in older patients. As with other 
aspects of these findings, objective measures of sleep parameters, and cellular markers of immune function status 
would be required in order to determine whether there are effects that are not captured by questionnaires and cat-
egorical data on treatment and viral load. Additionally, the present study did not examine other neuropsychiatric 
symptoms, or younger patients.
In instances where a longer than expected total sleep time is reported, it is reasonable to investigate quality 
since long sleep may be an indicator for disrupted or inefficient sleep, or an underlying medical condition47. In the 
present study, although the vast majority of participants considered their sleep to be of good quality. There were 
indications that quality was suboptimal, since one-third took longer than 30 minutes to fall asleep at night and 
one-third experienced restless sleep. Those with restless sleep were more likely to have hypertension and diabetes, 
suggesting that sleep quality warrants further investigation in this population.
A limitation of this study is that data collection took place throughout the year across all seasons, since par-
ticipants were part of the parent HAALSI study. Thus, seasonal variation in photoperiod, with daylight hours 
in Agincourt ranging between 10h37min and 13h39min, may have influenced self-reported total sleep time. 
Although this is a rural community, most (but not all) participants have access to electricity and thus light at 
night. In general, this population rose at, or before, sunrise and remained awake for a few hours after sunset, sim-
ilar to what has been observed in other rural African populations16,18. We were unable to obtain data on exposure 
to electricity at night, which would have been a helpful covariate in interpretation of these results. Further studies 
distinguishing between participants with and without access to electricity would be of interest, and would need to 
be performed before electrification of the region has been completed.
In conclusion, this cohort has the potential to address a number of important questions of current high inter-
est. What is not known is whether the longer total sleep time, and higher prevalence of long sleep (9 h or more) 
seen in this and other South African studies (i) reflects a greater sleep need, (ii) is a consequence of higher levels 
of unemployment, (iii) is protective against NCDs, and/or (iv) is underpinned by society-specific beliefs or value 
placed on sleep in South Africans of African origin. The data presented here provide a basis for further objective 
studies of the relationship between sleep quality and quantity to other risk factors in South African populations, a 
Self-reported 
sleep duration
Bad sleep 
quality Insufficient sleep Restless sleep Awakenings Snoring Gasping
Breathing 
stops
Quartile 1 - 
Quartile 4
Very bad/Bad 
vs. Very good/
Good
Sometimes/
Rarely/Never 
sufficient vs 
Often/Very often 
sufficient Yes vs No
At least once 
per week 
vs < Once per 
week Yes vs No Yes vs No Yes vs No
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
HIV+/ART+vs HIV− 1.10 (0.93, 1.29) 0.74 (0.49, 1.14) 0.99 (0.82, 1.20) 0.87 (0.71, 1.06) 1.00 (0.83, 1.21) 0.87 (0.68, 1.11) 1.06 (0.79, 1.41) 0.71 (0.46, 1.10)
HIV+/ART− vs HIV− 0.97 (0.79, 1.20) 0.84 (0.50, 1.42) 0.80 (0.62, 1.03) 0.88 (0.68, 1.13) 1.30 (1.04, 1.64) 0.91 (0.67, 1.23) 1.00 (0.68, 1.44) 1.09 (0.68, 1.74)
Table 4. Effect of HIV status and current antiretroviral therapy (ART) use on sleep characteristics among 
the entire cohort. Models were estimated using ordered logistic regression with the sleep variables treated as 
dependent variables in each of the 8 models. Models were adjusted for BMI and demographic characteristics 
(age group, sex, education group, employment status, marital status, wealth index quintile). OR: odds ratio, CI: 
confidence interval.
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complex and underexplored area of research48. On a more general note, it also provides valuable data about sleep 
habits in Africa, with the potential for future analysis of how it is affected by urbanisation and industrialisation. 
Finally, it offers a unique opportunity for a population-based comparison of the effects of treated and untreated 
HIV infection, which is increasingly unavailable elsewhere.
Methods
Setting. The HAALSI study23 was implemented in the Agincourt sub-district in Mpumalanga Province, South 
Africa, where the MRC/Wits Rural Public Health and Health Transitions Research Unit has been running the 
Agincourt Health and Demographic Surveillance System (Agincourt HDSS) site since 199221. In 2015, the study 
area of around 450 km2 included 31 villages with a population of approximately 116000 people. The primary 
health care system consists of six clinics, one public health center and one private-public community health 
center. The three hospitals that cover the district are 45–60 km from the study site. The social situation of this 
community and its services have improved in the past 20 years, but there are still gaps in areas such as electricity, 
water availability and paved roads among other important services21. Unemployment is highly prevalent, putting 
stress on families and leading to high rates of work migration and reliance on remittances as an important source 
of income49. Details on how census rounds were completed, and available information at the individual and 
household levels have been described elsewhere21.
Participants. The HAALSI participants were randomly selected from the MRC/Wits Agincourt Unit’s annual 
census of 2013. We defined the inclusion criteria as all males and females 40 years and older as of July 1, 2014, 
and permanently living in the study site during the 12 months prior to the census round of 2013. This sample 
included individuals randomly selected to participate in previous studies on ageing and adult health that were run 
in Agincourt HDSS in 200650 and 201051 to allow potential longitudinal analysis in this sub-sample of HAALSI 
participants. A sample of 6281 individuals who met the inclusion criteria was selected. Of these, 391 individuals 
were excluded (deceased or had migrated). The response rate of the 5890 eligible individuals was 85.9%, resulting 
in a final sample size of 505923. All participants belonged to the Shangaan ethnic group.
Study design. This is a cross-sectional, observational study in which each participant was interviewed at 
their home by a trained fieldworker. Interviews were performed using a computer-assisted personal interview 
(CAPI) on a laptop. The individual interview included an extensive set of questions on socio-demographic vari-
ables, self-reported health, and wellbeing, as well as anthropometric, blood pressure, and point of care measure-
ments for glucose, lipids, haemoglobin, and HIV.
Outcome measures. This investigation conformed with the tenets of the Declaration of Helsinki and 
was approved by the University of the Witwatersrand Human Research Ethics Committee (#M141159), the 
Harvard T.H. Chan School of Public Health Office of Human Research Administration (#13–1608), and the 
Mpumalanga Provincial Research and Ethics Committee. Written informed consent was obtained from all par-
ticipants. For illiterate participants a witness not linked to the study was present during the consenting process. 
The socio-demographic questions included information on age (presented in 10-year age bins), sex, years of 
completed education (no formal education, 1–7 y, 8–11 y, 12 or more years), marital status (never married, cur-
rently married, separated/divorced, widowed), employment status (not working, employed, homemaker), and 
socio-economic status (SES) as household wealth index quintiles52. SES was measured using the absolute values 
• Over the past 4 weeks, what time did you usually turn the lights off to go to sleep? (Hours, minutes)
• Over the past 4 weeks, what time did you usually get out of bed? (Hours, minutes)
• Over the past 4 weeks, how many hours do you think you actually slept each day? (Hours)
• During the past 4 weeks, how often did you wake up in the middle of the night or early morning? (“Never”/”Less 
than once per week”/”Once or twice a week”/”Three of more times a week”)
• During the past month, have you snored, or ever been told that you were snoring? (“Yes”/”No”)
• During the past month, have you snored loudly, or ever been told that you were snoring loudly? (“Yes”/”No”)
• During the last month, have you had, or ever been told that your breathing stops or you struggle for breath? 
(“Yes”/”No”)
• During the last month, have you had, or ever been told that you were snorting or gasping? (“Yes”/”No”)
• On a scale of 0 to 10, where 0 is “Does not interfere” and 10 is “Completely interferes”, select the one number that 
describes how, during the past 24 hours, pain has interfered with your sleep.
• Over the past 4 weeks, how would you rate your sleep quality overall? (“Very good”/”Fairly good”/”Fairly 
bad”/”Very bad”)
• During the past 4 weeks, how often could you not get to sleep within 30 minutes? (“Never”/”Less than once per 
week”/”Once or twice a week”/”Three of more times a week”)
• In your life, have you ever had any experience that was so frightening, horrible, or upsetting that, in the past 30 days 
you had more trouble than usual falling asleep or staying asleep?
• Much of the time in the past week, your sleep was restless. (“Yes”/”No”)
• How often during the past 4 weeks did you get enough sleep to feel rested upon waking up? 
(“Never”/”Rarely”/”Sometimes”/”Often”/”Very often”)
Table 5. Questionnaire items used in this study, with response options in parentheses.
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of a household asset score, based on five asset categories – ‘modern assets’, ‘power supply’, ‘water and sanitation’, 
‘quality of housing’, and ‘livestock assets’ – with increasing values corresponding to greater SES. This score was 
then divided in quintiles by household.
Anthropometric measurements included height (m), weight (kg), waist and hip circumferences (cm). BMI 
was calculated and participants classified as obese for BMI ≥ 30 kg/m2. Resting blood pressure (BP) was meas-
ured (Omron M6W® automated cuff) and participants classified as hypertensive for diastolic BP ≥ 90 mmHg or 
systolic BP ≥ 140 mmHg or participants reported current use of medication to treat hypertension53. Blood was 
collected using the finger prick technique for dried blood spots (DBS) and point of care measurements were 
taken for glucose (CareSense, De Puy Synthes, Rainham, MA), lipids (Cardiochek, PTS Diagnostics, Indianapolis, 
IN), and haemoglobin (HemoCue, Ängelholm, Sweden). Participants were classified as diabetic if their fasting 
glucose concentration was >7 mmol/L, or non-fasting concentration was ≥11.1 mmol/L or they reported using 
medication to control diabetes (American Diabetes Association. 2013). Participants were classified as having 
dyslipidaemia if they had elevated total cholesterol (≥6.21 mmol/L), or low HDL cholesterol (<1.19 mmol/L), or 
elevated LDL cholesterol (>4.1 mmol/L), or elevated triglycerides (>2.25 mmol/L) levels, or reported current use 
of cholesterolaemia treatment at time of interview. Anaemia was diagnosed if haemoglobin concentration was 
<11 g/dl) 1 49.
HIV status was determined by testing DBS for HIV antibodies with enzyme-linked immunosorbent assays 
[ELISA; Vironostika Uniform 11 (BioMérieux, Marcy-l'Étoile, France)] and confirmed using the Elecsys® HIV 
combi PT assay (Roche Diagnostics, Basel, Switzerland) and the ADVIA Centaur® HIV Ag/Ab Combo assay 
(Siemens Healthcare Diagnostics, Norwood, MA). Among those who tested HIV positive, assays were performed 
for viral load and to detect presence of ART. The Division of Clinical Pharmacology Laboratory of the University 
of Cape Town performed the ART assays, which detected metabolites of emtricitabine (FTC) or lamivudine 
(3TC) at a concentration as low as 0.02 µg/ml50. Either FTC or 3TC or both are included in all standard first- and 
second-line ART regimens in South Africa, so presence of metabolites of either drug was used to define those 
currently on ART.
A subset of the major individual components of the Pittsburgh Sleep Quality index (PSQI)24 were analysed 
in this study, in addition to a number of additional questions. All questions were translated from English to 
Shangaan and then back translated to English for consistency. The questionnaire in English is listed in Table 5 and 
the Shangaan version in Annex A. For the purposes of this study the question “Over the past 4 weeks, how many 
hours do you think you actually slept each day?” was used to determine self-reported sleep duration.
Data and statistical analyses. Data collected in the field were checked regularly for quality and com-
pleteness following HAALSI standard operating procedures. Descriptive data are presented as mean ± standard 
deviation, median (interquartile range) or count (%). Sex comparisons were carried out using an independent 
t-test, a Mann-Whitney U test or a Fisher’s Exact test. The association of demographic variables and sleep param-
eters were measured using logistic regression. Models for continuous variables were estimated using ordered 
logistic regression, with sleep duration, bedtime and wake time quartiles as the dependent variables. Quartiles 
of sleep duration were 4–7 h (quartile 1, n = 1,542), 8 h (quartile 2, n = 1,271), 9 h (quartile 3, n = 1,007), and 
10–14 h (quartile 4, n = 853). The quartiles for bed time were earlier than 20:00 (quartile 1, n = 667), 20:00 to 
<21:00 (quartile 2, n = 1,602), 21:00–21:30 (quartile 3, n = 1,622), and later than 21:30 (quartile 4, n = 1,109). 
The quartiles for wake time were earlier than 05:00 (quartile 1, n = 887), 05:00 (quartile 2, n = 1,626), >05:00 to 
06:00 (quartile 3, n = 1,537), and later than 06:00 (quartile 4, n = 893). We then modelled the association of sleep 
parameters and health conditions (hypertension, dyslipidaemia, diabetes, anaemia and HIV) also using logistic 
regression. In these analyses, each sleep parameter was evaluated in a separate model, adjusted for BMI and 
demographic characteristics (age group, sex, education group, employment status, marital status, wealth index 
quintile). For those participants who were HIV positive, we studied the association of being on ART and viral 
load on the main sleep variables (duration, quality, quantity, restless, awaking at night, snoring, gasping, noc-
turnal apnea). These models were adjusted for BMI and demographic characteristics (age group, sex, education 
group, employment status, marital status, wealth index quintile). Data were analysed using SAS software v9.3, and 
significance was accepted for p < 0.05.
Data Availability
The baseline data used in this study is publicly available at the Harvard Center for Population and Development 
Studies (HCPDS) program website (www.haalsi.org). The data is also accessible through the Interuniversity Con-
sortium for Political and Social Research (ICPSR) at the University of Michigan (www.icpsr.umich.edu), and 
the INDEPTH Data Repository (http://www.indepth-ishare.org/index.php/catalog/113). Further details can be 
obtained by emailing the corresponding author of this paper.
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